A NONPROFIT SINCE 2006

About MSCDA

MSCDA affairs are governed by a Board of Directors with day-to-day operations being facilitated by various other volunteers led by Petronella Barrow.
The Maryland Sickle Cell Disease Association, Inc. (MSCDA) is a 501 (c)(3), tax exempt non profit organization that was incorporated in 2006. MSCDA was formed by concerned parents and interested individuals seeking to improve the lives of persons affected by sickle cell disease in Maryland. MSCDA seeks to work collaboratively with patients, families, healthcare providers, federal and state agencies and other community based organizations to promote advocacy, education, research and excellent healthcare delivery.
GET TO KNOW US

MSCDA Team

MSCDA affairs are governed by a Board of Directors with day-to-day operations being facilitated by various other volunteers led by Petronella Barrow.

MSCDA Board of Directors

Derek Robertson
President
Benjamin Joseph
Vice President
GET IN TOUCH

We'd Love to Hear from You

Whether you are looking to learn more about our services, and how we can help, or you’re looking for volunteer opportunities, to make a donation, or have any questions about the Maryland Sickle Cell Disease Association, please reach out!
CONTACT US
KEEP IN TOUCH
Sign up for our email list, or follow us on social media, to stay in-the-know about the Maryland Sickle Cell Disease Association
Scroll to Top

Breaking News

FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease

On December 8, 2023, “The U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. Additionally, one of these therapies, Casgevy, is the first FDA-approved treatment to utilize a type of novel genome editing technology, signaling an innovative advancement in the field of gene therapy."